{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T08:49:58Z","timestamp":1787993398172,"version":"build-2784847793"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Vagus nerve stimulation (VNS) is an effective treatment for drug-resistant epilepsy (DRE). The present study evaluated the efficacy of VNS in pediatric patients with DRE of monogenic etiology. A total of 20 patients who received VNS treatment at our center were followed up every 3 months through outpatient visits or a remote programming platform. The median follow-up time was 1.4 years (range: 1.0\u20132.9). The rate of response to VNS at 12 months of follow-up was 55.0% (11\/20) and the seizure-free rate was 10.0% (2\/20). We found that 75.0% (3\/4) of patients with an <jats:italic>SCN1A<\/jats:italic> variant had a &amp;gt;50% reduction in seizure frequency. Patients with pathogenic mutations in the <jats:italic>SLC35A2, CIC, DNM1, MBD5, TUBGCP6, EEF1A2<\/jats:italic>, and <jats:italic>CHD2<\/jats:italic> genes or duplication of X q28 (<jats:italic>MECP2<\/jats:italic> gene) had a &amp;gt;50% reduction in seizure frequency. Compared with the preoperative electroencephalography (EEG), at 6, 12, 18, and 24 months after stimulator implantation, the percentage of the patients whose background frequency increased &amp;gt;1.5 Hz was respectively, 15.0% (3\/20), 50.0% (10\/20), 58.3% (7\/12) and 62.5% (5\/8); the percentage of the patients whose interictal EEG showed a &amp;gt;50% decrease in spike number was respectively 10% (2\/20), 40.0% (8\/20), 41.6% (5\/12) and 50.0% (4\/8). In the 9 patients with no response to VNS treatment, there was no difference in terms of spike number and background frequency between preoperative and postoperative EEG. Five of the 20 children (25.0%) reached new developmental milestones or acquired new skills after VNS compared to the preoperative evaluation. The efficacy of VNS in pediatric patients with DRE of monogenic etiology is consistent with that in the overall population of pediatric DRE patients. Patients with Dravet syndrome (DS), tuberous sclerosis complex (TSC), or Rett syndrome\/<jats:italic>MECP2<\/jats:italic> duplication syndrome may have a satisfactory response to VNS, but it is unclear whether patients with rare variants of epilepsy-related genes can benefit from the treatment.<\/jats:p>","DOI":"10.3389\/fneur.2022.951850","type":"journal-article","created":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T07:04:05Z","timestamp":1662015845000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Vagus nerve stimulation in children with drug-resistant epilepsy of monogenic etiology"],"prefix":"10.3389","volume":"13","author":[{"given":"Han","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taoyun","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingzhu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia."},{"key":"B2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.yebeh.2010.10.017","article-title":"Vagus nerve stimulation in 436 consecutive patients with treatment-resistant epilepsy: long-term outcomes and predictors of response","volume":"20","author":"Elliott","year":"2011","journal-title":"Epilepsy Behav."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.3892\/mmr.2020.10999","article-title":"Genetic variations associated with pharmacoresistant epilepsy","volume":"21","author":"C\u00e1rdenas-Rodr\u00edguez","year":"2020","journal-title":"Mol Med Rep."},{"key":"B4","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1109\/EMBC.2014.6943851","article-title":"The study on a real-time remote monitoring system for Parkinson's disease patients with deep brain stimulators","volume-title":"2014 36th Annual International Conference of the IEEE Engineering in Medicine and Biology Society","author":"Chen","year":"2014"},{"key":"B5","doi-asserted-by":"publisher","first-page":"106246","DOI":"10.1016\/j.eplepsyres.2019.106246","article-title":"Remote programming: a convenient and cost-effective measure of vagus nerve stimulation for children with epilepsy","volume":"159","author":"Xie","year":"2020","journal-title":"Epilepsy Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.seizure.2019.02.010","article-title":"Predictors of seizure reduction outcome after vagus nerve stimulation in drug-resistant epilepsy","volume":"66","author":"Wang","year":"2019","journal-title":"Seizure."},{"key":"B7","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/epi.17152","article-title":"Norwegian population-based study of long-term effects, safety, and predictors of response of vagus nerve stimulation treatment in drug-resistant epilepsy: the NORPulse study","volume":"63","author":"Kostov","year":"2022","journal-title":"Epilepsia."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.3171\/2011.7.JNS11977","article-title":"Vagus nerve stimulation for epilepsy: a meta-analysis of efficacy and predictors of response","volume":"115","author":"Englot","year":"2011","journal-title":"J Neurosurg."},{"key":"B9","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00381-009-1069-2","article-title":"Vagal nerve stimulation for drug-resistant epilepsies in different age, aetiology and duration","volume":"26","author":"Colicchio","year":"2010","journal-title":"Childs Nerv Syst."},{"key":"B10","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.pedneo.2020.07.010","article-title":"Therapeutic effects of children with refractory epilepsy after vagus nerve stimulation in Taiwan","volume":"61","author":"Li","year":"2020","journal-title":"Pediatr Neonatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2022.1.PEDS222","article-title":"The role of vagus nerve stimulation in genetic etiologies of drug-resistant epilepsy: a meta-analysis","volume":"18","author":"Hajtovic","year":"2022","journal-title":"J Neurosurg Pediatr."},{"key":"B12","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.eplepsyres.2018.07.013","article-title":"Vagus nerve stimulation for the treatment of refractory epilepsy in the CDKL5 deficiency disorder","volume":"146","author":"Lim","year":"2018","journal-title":"Epilepsy Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.braindev.2016.10.007","article-title":"Amelioration of intractable epilepsy by adjunct vagus nerve stimulation therapy in a girl with a CDKL5 mutation","volume":"39","author":"Baba","year":"2017","journal-title":"Brain Dev."},{"key":"B14","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.braindev.2020.12.006","article-title":"Clinical manifestations and epilepsy treatment in Japanese patients with pathogenic CDKL5 variants","volume":"43","author":"Kobayashi","year":"2021","journal-title":"Brain Dev."},{"key":"B15","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/j.1469-8749.2006.tb01340.x","article-title":"Vagus nerve stimulation for treatment of epilepsy in Rett syndrome","volume":"48","author":"Wilfong","year":"2006","journal-title":"Dev Med Child Neurol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00381-018-3723-z","article-title":"Vagal nerve stimulation for medically refractory epilepsy in Angelman syndrome: a series of three cases","volume":"34","author":"Tomei","year":"2018","journal-title":"Childs Nerv Syst."},{"key":"B17","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3171\/2016.7.PEDS1651","article-title":"Epilepsy surgery in patients with autism","volume":"19","author":"Kokoszka","year":"2017","journal-title":"J Neurosurg Pediatr."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1111\/j.1528-1167.2009.02108.x","article-title":"Epilepsy in Angelman syndrome: a questionnaire-based assessment of the natural history and current treatment options","volume":"50","author":"Thibert","year":"2009","journal-title":"Epilepsia."},{"key":"B19","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1177\/08830738020170101805","article-title":"Intractable epilepsy with ring chromosome 20 syndrome treated with vagal nerve stimulation: case report and review of the literature","volume":"17","author":"Chawla","year":"2002","journal-title":"J Child Neurol."},{"key":"B20","doi-asserted-by":"crossref","DOI":"10.1017\/S0012162206240167","article-title":"Epilepsy responds to vagus nerve stimulation in ring chromosome 20 syndrome","volume-title":"Dev Med Child Neurol","author":"Parr","year":"2006"},{"key":"B21","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1017\/S0012162205000642","article-title":"Ring chromosome 20 syndrome with intractable epilepsy","volume":"47","author":"Alpman","year":"2005","journal-title":"Dev Med Child Neurol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.eplepsyres.2006.09.006","article-title":"More severe epilepsy and cognitive impairment in the offspring of a mother with mosaicism for the ring 20 chromosome","volume":"73","author":"Herrg\u00e5rd","year":"2007","journal-title":"Epilepsy Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.gene.2013.08.096","article-title":"A recurrent KCNT1 mutation in two sporadic cases with malignant migrating partial seizures in infancy","volume":"531","author":"Ishii","year":"2013","journal-title":"Gene."},{"key":"B24","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/humu.23731","article-title":"SLC35A2-CDG: functional characterization, expanded molecular, clinical, and biochemical phenotypes of 30 unreported Individuals","volume":"40","author":"Ng","year":"2019","journal-title":"Hum Mutat."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.951850\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T07:04:10Z","timestamp":1662015850000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.951850\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,1]]},"references-count":24,"alternative-id":["10.3389\/fneur.2022.951850"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.951850","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,1]]},"article-number":"951850"}}